Intra-aortic balloon pump support did not improve short- or long-term survival in patients with MI-related cardiogenic shock but was linked to increased complications.
Does intra-aortic balloon pump support improve survival in patients with myocardial infarction-related cardiogenic shock?
IABP use in MI-related cardiogenic shock does not improve survival and is associated with increased complications, supporting current guidelines against its routine use.
Absolute Event Rate: 0% vs 0%
IABP did not improve short- or long-term survival in patients with MI-related cardiogenic shock but was linked to increased complications, supporting current guideline recommendations against its routine use.
Völz et al. (Fri,) reported a other. Intra-aortic balloon pump support did not improve short- or long-term survival in patients with MI-related cardiogenic shock but was linked to increased complications.